Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.48.12.4687-4692.2004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Interpretation of Genotype and Pharmacokinetics for Resistance to Fosamprenavir-Ritonavir-Based Regimens in Antiretroviral-Experienced Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Journal of Clinical Microbiology
Microbiology
1999English

Association of a Novel Human Immunodeficiency Virus Type 1 Protease Substrate Cleft Mutation, L23I, With Protease Inhibitor Therapy and in Vitro Drug Resistance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Variant Human Immunodeficiency Virus Type 1 Proteases and Response to Combination Therapy Including a Protease Inhibitor

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Estimate of the Frequency of Human Immunodeficiency Virus Type 1 Protease Inhibitor Resistance Within Unselected Virus Populations in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy